Table 2 AKI patients characteristics by 28-day mortality
Characteristic | AKI patients (n = 1021) M (Q1, Q3) Number (%) | Survivors (n = 694) M (Q1, Q3) Number (%) | Non-survivors (n = 327) M (Q1, Q3) Number (%) | P value |
|---|---|---|---|---|
Age (years) | 75 (68-82) | 74 (67-81) | 78 (70-83) | < 0.001 |
Male gender | 615 (60.2) | 420 (60.5) | 195 (59.6) | 0.967 |
Baseline creatinine (μmol/L) | 82.0 (72.9-95.0) | 81.0 (72.0-94.8) | 84.0 (75.0-95.2) | 0.774 |
BMI | 24 (21-26) | 24 (21-26) | 23 (21- 25) | 0.012 |
Severity of illness | ||||
mNUTRIC | 5 (3-6) | 4 (3-6) | 6 (5-7) | < 0.001 |
APACHEII | 18 (14-25) | 16 (12-21) | 24 (18- 30) | < 0.001 |
SAPSII | 43 (34-57) | 39 (31-49) | 55 (43-69) | < 0.001 |
SOFA | 7 (4-10) | 6 (4-9) | 9 (6-12) | < 0.001 |
ICU course | ||||
Vasoactive therapy | 439 (43.0) | 301 (43.4) | 138 (42.2) | 0.940 |
MV | 687 (67.3) | 452 (65.1) | 235 (71.9) | 0.101 |
sepsis | 472 (46.2) | 240 (34.6) | 232 (70.9) | < 0.001 |
Staging of AKI 1 | 450 (44.1) | 373 (53.7) | 77 (23.5) | |
2 | 246 (24.1) | 168 (24.2) | 78 (23.9) | < 0.001 |
3 | 325 (31.8) | 153 (22.1) | 172 (52.6) | |
RRT | 174 (17.0) | 77 (11.1) | 97 (29.7) | < 0.001 |
Organ support | ||||
single organ | 477 (46.7) | 340 (49.0) | 137 (41.9) | |
dual organ | 332 (32.5) | 212 (30.5) | 120 (36.7) | < 0.001 |
multiorgan | 53 (5.2) | 22 (3.2) | 31 (9.5) | |
Outcomes | ||||
ICU LOS (days) | 6 (3-12) | 5 (3-12) | 6 (4-11) | 0.722 |